Successful long-term prophylaxis with human plasma-derived C1 inhibitor in planning and carrying out pregnancy

Allergol Int. 2018 Jan;67(1):144-146. doi: 10.1016/j.alit.2017.05.008. Epub 2017 Jun 16.

Authors

Susana Calaforra-Méndez¹, Ethel Ibáñez Echevarría¹, Carolina Perales Chordá¹, María Verónica Pacheco-Coronel², Agustín Fernández Llópez³, Dolores Hernández Fernández de Rojas⁴

Affiliations

¹ Hospital Universitari i Politecnic La Fe, Valencia, Spain.
² Allergy Department, Hospital Universitari La Fe, Valencia, Spain.
³ Hospital 9 de Octubre, Valencia, Spain.
⁴ Hospital Universitari i Politecnic La Fe, Valencia, Spain. Electronic address: [email protected].

PMID: 28624252
DOI: 10.1016/j.alit.2017.05.008

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adult
Angioedemas, Hereditary / blood
Angioedemas, Hereditary / diagnosis
Angioedemas, Hereditary / prevention & control*
Biomarkers
Complement C1 Inhibitor Protein / administration & dosage
Complement C1 Inhibitor Protein / therapeutic use*
Disease Progression
Female
Humans
Pregnancy
Pregnancy Complications / prevention & control*
Premedication*
Time Factors
Treatment Outcome

Substances

Biomarkers
Complement C1 Inhibitor Protein
SERPING1 protein, human